ACE2 and breast carcinoma: To prove our conjecture, we exposed breast cancer cells (MDA-468, MDA-231, MCF-7, T47D) with low doses of chemotherapeutic drugs for 72 h and examined ACE2 expression by qRT-PCR and western blot.